Literature DB >> 14551311

c-kit proto-oncogene product is rarely detected in colorectal adenocarcinoma.

Rebecca Yorke, Minnie Chirala, Mamoun Younes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14551311     DOI： 10.1200/JCO.2003.99.213

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  KIT Signaling Promotes Growth of Colon Xenograft Tumors in Mice and Is Up-Regulated in a Subset of Human Colon Cancers.

Authors:  Evan C Chen; Taylor A Karl; Tomer Kalisky; Santosh K Gupta; Catherine A O'Brien; Teri A Longacre; Matt van de Rijn; Stephen R Quake; Michael F Clarke; Michael E Rothenberg
Journal:  Gastroenterology       Date:  2015-05-28       Impact factor: 22.682

2.  Immunohistochemical detection of receptor tyrosine kinases c-kit, EGF-R, and PDGF-R in colorectal adenocarcinomas.

Authors:  Jan Friederichs; Claus W H von Weyhern; Robert Rosenberg; Dietrich Doll; Raymonde Busch; Florian Lordick; Jörg Rüdiger Siewert; Mario Sarbia
Journal:  Langenbecks Arch Surg       Date:  2009-03-12       Impact factor: 3.445

3.  A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation.

Authors:  Ana Preto; Cátia Moutinho; Sérgia Velho; Carla Oliveira; Ana Paula Rebocho; Joana Figueiredo; Paula Soares; José Manuel Lopes; Raquel Seruca
Journal:  Virchows Arch       Date:  2007-05-09       Impact factor: 4.064

4.  KITLG is a novel target of miR-34c that is associated with the inhibition of growth and invasion in colorectal cancer cells.

Authors:  Shu Yang; Wen-shuai Li; Fang Dong; Hai-mei Sun; Bo Wu; Jun Tan; Wan-jing Zou; De-shan Zhou
Journal:  J Cell Mol Med       Date:  2014-09-12       Impact factor: 5.310

5.  Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness.

Authors:  Helge Siemens; Rene Jackstadt; Markus Kaller; Heiko Hermeking
Journal:  Oncotarget       Date:  2013-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.